Mirae Asset Global Investments Co., Ltd.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1569395
SEOUL, M5
Position in NBIX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$1,371,149
-$999,680 QoQ
Shares Held
10,408
-37.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Mirae Asset Global Investments Co., Ltd. holds $22,631,351 across 30 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
94,998 | $11,229,712 | |
| 2 | VTRS |
Viatris Inc
|
283,050 | $3,824,005 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
4,828 | $2,862,907 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
10,408 | $1,371,149 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
14,385 | $692,637 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
21,502 | $514,542 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
14,503 | $442,051 | |
| 8 | ALKS |
Alkermes plc.
|
8,692 | $307,349 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,371,149 | 10,408 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $2,370,829 | 16,716 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,066,533 | 14,721 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,572,758 | 12,513 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,501,616 | 13,577 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $2,232,867 | 16,358 | Shares | Defined | 2025-01-27 | |
| 2024-09-30 | $1,547,749 | 13,433 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $527,551 | 3,832 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,834,335 | 13,300 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $3,555,936 | 26,988 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $3,269,474 | 29,062 | Shares | Defined | 2023-10-26 | |
| 2023-06-30 | $3,353,683 | 35,564 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $3,977,235 | 39,293 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $3,180,686 | 26,630 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,453,841 | 32,519 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $3,619,626 | 37,132 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,603,936 | 38,442 | Shares | Defined | 2022-06-02 | |
| 2021-12-31 | $3,705,404 | 43,506 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $4,429,794 | 46,187 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,945,838 | 40,545 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $4,050,460 | 41,650 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,922,375 | 51,355 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $3,810,722 | 39,629 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $4,690,046 | 38,443 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $4,002,849 | 46,249 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||